Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.
about
Justicidin B: A Promising Bioactive LignanThe Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical DiseasesUtilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas DiseaseDrug resistance in eukaryotic microorganisms.Ten years of Chagas disease research: Looking back to achievements, looking ahead to challengesPopulation pharmacokinetics of benznidazole in adult patients with Chagas disease.Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.Opportunities and challenges in chronic Chagas cardiomyopathyEnalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi.Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas DiseaseSerological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern ArgentinaCongenital Chagas' disease transmission in the United States: Diagnosis in adulthood.Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead.Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.Long-term comparative pharmacovigilance of orally transmitted Chagas disease: first report.Assessing anti-T. cruzi candidates in vitro for sterile cidality.Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group.Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease.Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.Lack of Efficacy of Liposomal Amphotericin B Against Acute and Chronic Trypanosoma cruzi Infection in Mice.Trypanosoma cruzi I genotype among isolates from patients with chronic Chagas disease followed at the Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ, Brazil).Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.Experimental and Clinical Treatment of Chagas Disease: A Review.Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.In vitro, in silico and in vivo analysis of novel aromatic amidines against Trypanosoma cruzi.4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice.Bugging out over Chagas: Bioluminescent protozoans and old drugs might help unravel kissing-bug disease.Adverse systemic reaction to benznidazole.Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With BenznidazoleOn the investigation of hybrid quinones: synthesis, electrochemical studies and evaluation of trypanocidal activity
P2860
Q26747034-138927FB-45DD-4836-A0FA-18E19E695467Q26797488-B671A181-DB5A-4947-B67E-3BBCCE241ADEQ28546644-1D6C6B09-3E1E-4D53-9271-0F6E6723C93FQ30248243-B9AF1AFC-06C3-4960-A1AD-018BFA5D0140Q33584473-388BAF57-689B-40CE-8377-2631735B2A14Q35607812-44055AEE-47E0-40DE-8B3B-54F8405FD94FQ35884080-B2E07561-59A9-4804-9B17-A602B1CCC261Q36108560-BB9154C3-91EC-4C26-83B1-B6BA06CD35EBQ36436221-3F795D96-96AC-4951-BE68-ACF90A5919B7Q36455741-5AF125E2-C172-4A50-BFCC-4E2B25557F31Q36933398-68D44837-C351-4EF8-AB83-759C188AA204Q37007518-5E81F61B-6398-4711-AAB8-DB14DC458665Q37161472-2547A5B0-1DCF-4A2A-9EC8-59E51A03821CQ38412987-95A68941-68BC-49E0-A70C-F47294CABBCDQ38683260-5E076353-BB6B-463A-9FFB-353DDE4E3D42Q38867072-31A61D7A-0F83-4550-B6CC-42CD9D5E36A5Q38929035-C47F30A7-36B6-468F-B783-962A3ABCB7F9Q39001919-8F737E8B-0820-426A-A744-533B0141F849Q39214859-5B11C8D9-70D2-40E0-8246-4695FD2A979DQ39282269-75A6F236-327E-4C83-B7CC-E70C64739638Q40088256-FA39FA39-5023-4A16-A99D-EB47656CF12CQ40284487-EE4C5A82-25F6-478D-A217-32FCB2B93F15Q40342687-140E1039-5C9A-4D06-AAC0-AE8D1578CF77Q41073713-ECA6DBE0-F0DF-42E6-BE93-B859D1A6C02DQ41989175-0158C7DE-B075-4F7D-8693-8DE75467D85FQ42625257-9437EE4A-4F72-4066-A22C-E0A7618CC7FDQ47371103-B05281F3-1D5D-4014-97A2-25E32CA50170Q48342608-00ABE116-E21A-4B38-8995-7E353ECC4CD6Q50088418-ED6B6E7A-DA63-470C-824A-88A168F36F3FQ50099507-6BC0364F-2884-4678-84B3-092A534998A2Q52648078-F516C5AC-2F88-4D4D-8ECF-1EE5435F6837Q52836242-E8C7A813-73A6-489E-A5DB-0B837F490DD0Q54417952-F85CB056-EFCE-4A79-95B1-CDA3CA1AFA0EQ58573679-62087DF3-CD92-47DC-AA2B-73C0BA933864Q58856160-04119546-0590-4D00-9D51-224100058BD0
P2860
Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Recent clinical trials for the ...... , challenges and perspectives.
@en
type
label
Recent clinical trials for the ...... , challenges and perspectives.
@en
prefLabel
Recent clinical trials for the ...... , challenges and perspectives.
@en
P2860
P356
P1476
Recent clinical trials for the ...... , challenges and perspectives.
@en
P2093
Julio A Urbina
P2860
P304
P356
10.1111/JEU.12184
P577
2014-11-13T00:00:00Z